Metformin Use and Cognitive Dysfunction Among Patients with Diabetes Mellitus

Journal of the American Medical Directors Association

Volumn 17, Issue 11, 2016, Pages 1063-1065

  Liccini, Anthony ^a   Malmstrom, Theodore K ^a   Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA; ANTIDIABETIC AGENT;

ADULT; CLOCK DRAWING TEST; COGNITION; COGNITION ASSESSMENT; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTROSPECTION; LETTER; MAJOR CLINICAL STUDY; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PHARMACEUTICAL CARE; RAPID COGNITIVE SCREEN; WORD RECOGNITION;

COGNITIVE DYSFUNCTION; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN;

EID: 84992539229     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2016.08.026     Document Type: Letter

References (12)

1. 1 Shaik, M.A., Chan, Q.L., Xu, J., et al. Risk factors of cognitive impairment and brief cognitive tests to predict cognitive performance determined by a formal neuropsychological evaluation of primary health care patients. J Am Med Dir Assoc 17 (2016), 343–347.
2. 2 Seitz, D.P., Adunuri, N., Gill, S.S., Rochon, P.A., Prevalence of dementia and cognitive impairment among older adults with hip fractures. J Am Med Dir Assoc 12 (2011), 556–564.
3. 3 Uemura, K., Shimada, H., Makizako, H., et al. Effects of mild cognitive impairment on the development of fear of falling in older adults: A prospective cohort study. J Am Med Dir Assoc 16 (2015), 1104.e9–1104.e13.
4. 4 Morley, J.E., Morris, J.C., Berg-Weger, M., et al. Brain health: The importance of recognizing cognitive impairment: An IAGG consensus conference. J Am Med Dir Assoc 16 (2015), 731–739.
5. 5 Sinclair, A., Morley, J.E., How to manage diabetes mellitus in older persons in the 21st century: Applying these principles to long term diabetes care. J Am Med Dir Assoc 14 (2013), 777–780.
6. 6 Morley, J.E., Diabetes mellitus: “The times they are a-changin.”. J Am Med Dir Assoc 13 (2012), 574–575.
7. 7 Sinclair, A., Morley, J.E., Rodriguez-Manas, L., et al. Diabetes mellitus in older people: Position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc 13 (2012), 497–502.
8. 8 Ng, T.P., Feng, L., Yap, K.B., et al. Long-term metformin usage and cognitive function among older adults with diabetes. J Alzheimers Dis 41 (2014), 61–68.
9. 9 Guo, M., Mi, J., Jiang, Q.M., et al. Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus. Clin Exp Pharmacol Physiol 41 (2014), 650–656.
10. 10 Liccini, A., Malmstrom, T.K., Frailty and sarcopenia as predictors of adverse health outcomes in older persons with diabetes mellitus. J Am Med Dir Assoc 17 (2016), 846–851.
11. 11 Malmstrom, T.K., Voss, V.B., Cruz-Oliver, D.M., et al. The Rapid Cognitive Screen (RCS): A point-of-care screening for dementia and mild cognitive impairment. J Nutr Health Aging 19 (2015), 741–744.
12. 12 Morley, J.E., Malmstrom, T.K., Rodriguez-Manas, L., Sinclair, A.J., Frailty, sarcopenia and diabetes. J Am Med Dir Assoc 15 (2014), 853–859.